The relationship of akathisia with treatment emergent suicidality among patients with first-episode schizophrenia treated with haloperidol or risperidone

Pharmacopsychiatry

Volumn 45, Issue 7, 2012, Pages 292-296

  Seemuller F ^a   Lewitzka, U ^b,c   Bauer, M ^b   Meyer, S ^a   Musil, R ^a   Schennach, R ^a   Riedel, M ^a,d   Doucette, S ^c   Moller H J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c DALHOUSIE UNIVERSITY   (Canada)

^d Vinzenz von Paul Hospital   (Germany)

Author keywords

akathisia; anxiety; first episode schizophrenia; suicidality

Indexed keywords

HALOPERIDOL; RISPERIDONE;

ADULT; AKATHISIA; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; FEMALE; HUMAN; MALE; ONSET AGE; PERCEPTION; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; SCORING SYSTEM; SUICIDAL IDEATION; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AGE FACTORS; AKATHISIA, DRUG-INDUCED; ANTIPSYCHOTIC AGENTS; ANXIETY; FEMALE; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUICIDAL IDEATION;

EID: 84869501727     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0032-1309004     Document Type: Article

References (17)

1. van Putten T. The many faces of akathisia. Compr Psychiatry: 1975; 16 43 47
2. Falkai P., Wobrock T., Lieberman J. et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia. World J Biol Psychiatry: 2005; 6 132 191
3. Gaebel W., Riesbeck M., Wölver W. et al. German Study Group on First-Episode Schizophrenia Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Networt on Schizophrenia. J Clin Psychiatry: 2007; 68 1763 1774
4. Girgis R. R., Phillips M. R., Li X. et al. Clozapine v. chlorpromazine in treatment-naïve, first-episode schizophrenia: 9-year outcomes of a randomised clinical trial. Br J Psychiatry: 2011; 199 281 288
5. Hawton K., Sutton L., Haw C. et al. Schizophrenia and suicide: systematic review of risk factors. Br J Psychiatry: 2005; 187 9 20
6. Hansen L. A critical review of akathisia - and its possible association with suicidal behaviour. Human Psychopharmacology: 2001; 16 495 505
7. Seemüller F., Schennach R., Mayr A. et al. Riedel M for the German Study Group on First-Episode Schizophrenia Akathisia and suicidal ideation in first episode schizophrenia (FES). J Clin Psychopharmacol submitted
8. Möller H. J., Riedel M., Jäger M. et al. Short-term treatment with Risperidone or Haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia. Int J Neuropsychopharmacol: 2008; 11 985 997
9. Kay S. R., Fiszbein A., Opler L. A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bull: 1987; 13 261 276
10. Hamilton M. A rating scale for depression. J Neurol, Neurosurg Psychiatry: 1960; 23 56 62
11. Guy W. National Institut for Mental Health. Clinical Global Impressions. In: Guy W. (ed.). ECDEU assessment manual for psychopharmacology. Rev. edn. Rockville, MD Institute of Mental Health: 1976; 217 222
12. Frances A., Pincus H. A., First M. B. The Global Assessment of Functioning Scale (GAF). Diagnostic and Statistical Manual of Mental Disorders- IV. Washington DC American Psychiatric Association: 1994
13. th edn. Washington DC American Psychiatric Association: 1994
14. Fleischhacker W. W., Bergmann K. J., Perovich R. et al. The Hillside Akathisia Scale: a new rating instrument for neuroleptic-induced akathisia. Psychopharmacol Bull: 1989; 25 222 226
15. Fava M., Rush A. J., Alpert J. E. et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry: 2008; 165 342 351
16. Atbaşolu E. C., Schultz S. K., Andreasen N. C. The relationship of akathisia with suicidality and depersonalization among patients with schizophrenia. J Neuropsychiatry Clin Neurosci: 2001; 13 336 341
17. Kane J. M., Fleischhacker W. W., Hansen L. et al. Akathisia: an updated review focussing on second-generation antipsychotics. J Clin Psychiatry: 2009; 70 627 643